Esophageal Cancer Clinical Trial
Evaluate Esophageal Reinforcement With ACell MatriStem Surgical Matrix: A Degradable Biologic Scaffold Material
The purpose of this study is to see if implanting MatriStem will lower the risk of one of the more common complications after stomach or esophagus surgery.
Patient 18 years of age or older
Pathologically confirmed Gastric, Gastroesophageal Junction (GEJ) or Esophageal, adenocarcinoma at either MSKCC or a participating site (biopsy may be performed at other institutions but slides must be confirmed at MSKCC or a participating site, as is routine care at our institution)
Patient undergoing any resection requiring an anastomosis to the esophagus for curative intent. Including but not limited to esophagectomy or total gastrectomy.
Subject is willing to provide written informed consent
Subject is willing and able to comply with the follow-up regimen
Pregnant or lactating women
Intraoperative evidence of metastatic or locally-unresectable disease
Patients with known sensitivity or allergy to porcine materials.
Patients undergoing any resection requiring an anastomosis to the esophagus for palliative intent.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 3 Locations for this study
Basking Ridge New Jersey, , United States
Harrison New York, 10604, United States
New York New York, 10065, United States
Houston Texas, 77030, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.